Why Fatigue Persists After COVID-19
For millions of people worldwide, the acute phase of COVID-19 has resolved — but the fatigue has not. Post-COVID fatigue is not ordinary tiredness. It is a profound, disabling exhaustion that does not improve with rest, worsens after physical or cognitive exertion (post-exertional malaise), and can persist for months or years after the initial infection. The World Health Organization recognizes post-COVID condition as a significant clinical entity affecting an estimated 10–20% of COVID-19 survivors.
At St. George Hospital in Bad Aibling, Germany, Dr. Julian Douwes and our medical team — in collaboration with Dr. Beate Jaeger, a leading researcher in post-COVID microcirculation — have developed a comprehensive inpatient program specifically for post-COVID fatigue. Our approach targets the biological mechanisms driving the fatigue, not merely the symptom itself.
The Biology Behind Post-COVID Fatigue
Post-COVID fatigue is not psychosomatic. Multiple converging biological mechanisms have been identified, and understanding them is essential for effective treatment.
Mitochondrial Dysfunction
Mitochondria — the energy-producing organelles in every cell — are directly damaged by SARS-CoV-2 infection. Research suggests several mechanisms:
- Viral hijacking of mitochondrial machinery — the virus co-opts mitochondrial proteins for its own replication
- Oxidative stress — the inflammatory response generates reactive oxygen species that damage mitochondrial membranes and DNA
- NAD+ depletion — the immune response to COVID-19 consumes large quantities of NAD+, a coenzyme essential for mitochondrial energy production
- Impaired electron transport chain function — leading to reduced ATP (energy) output even after the virus is cleared
The result is a cellular energy crisis. Your cells simply cannot produce enough energy to meet normal demands — which is why post-COVID fatigue feels fundamentally different from the tiredness of a bad night’s sleep.
Microclots and Impaired Microcirculation
One of the most important discoveries in post-COVID research — extensively studied by Dr. Beate Jaeger and colleagues — is the role of microclots and endothelial dysfunction in persistent symptoms. Key findings include:
- Fibrin amyloid microclots — abnormal, inflammatory clot formations that resist normal fibrinolysis (clot breakdown)
- Endothelial damage — the cells lining blood vessels are directly infected by SARS-CoV-2, leading to persistent vascular inflammation
- Impaired microcirculation — small blood vessels fail to deliver adequate oxygen and nutrients to tissues
- Tissue hypoxia — organs and muscles receive insufficient oxygen, contributing directly to fatigue and exercise intolerance
This microclot hypothesis represents an important research direction in understanding why post-COVID fatigue persists long after the virus has been cleared. While research is ongoing, the clinical implications are significant: treatments that improve microcirculation and address endothelial dysfunction may help resolve fatigue that does not respond to rest alone.
Autonomic Nervous System Dysfunction
COVID-19 can disrupt the autonomic nervous system — the body’s automatic regulatory system controlling heart rate, blood pressure, digestion, and temperature. This dysautonomia manifests as:
- POTS (Postural Orthostatic Tachycardia Syndrome) — heart rate spikes upon standing
- Orthostatic intolerance — dizziness, lightheadedness, fatigue upon upright posture
- Exercise intolerance — disproportionate fatigue and heart rate response to minimal exertion
- Temperature dysregulation — chills, flushing, poor thermoregulation
Autonomic dysfunction directly contributes to fatigue by impairing the body’s ability to regulate blood flow, oxygen delivery, and energy expenditure in response to daily activities.
Persistent Immune Activation
In many post-COVID patients, the immune system remains in a state of chronic activation long after the virus is cleared. Elevated inflammatory cytokines — including IL-6, TNF-alpha, and interferon-gamma — maintain a low-grade inflammatory state that drives fatigue, cognitive dysfunction, and malaise. This “inflammatory hangover” may also reflect viral persistence in tissue reservoirs, immune dysregulation, or reactivation of latent viruses (such as Epstein-Barr virus).
Post-COVID Fatigue Treatment Options
NAD+ IV Therapy
Given the central role of mitochondrial dysfunction in post-COVID fatigue, NAD+ IV therapy is one of the most targeted interventions available. By delivering NAD+ directly into the bloodstream, we bypass the limitations of oral supplementation and restore cellular energy production at its source.
At St. George Hospital, NAD+ infusions are administered as part of our daily treatment protocol during the inpatient stay. Patients typically receive 500–750 mg per session, infused over 2–4 hours. Most patients report noticeable improvement in energy and cognitive clarity within the first several sessions.
Interval Hypoxia-Hyperoxia Training (IHHT)
IHHT — also known as altitude training or intermittent hypoxic training — is a non-invasive therapy that stimulates mitochondrial regeneration. The patient breathes alternating periods of low-oxygen (hypoxia) and high-oxygen (hyperoxia) air through a mask while resting comfortably.
The mechanism is elegant: brief hypoxic intervals trigger the body to eliminate damaged, dysfunctional mitochondria (mitophagy) and stimulate the production of new, healthy mitochondria (mitochondrial biogenesis). Over a course of 10–15 sessions, this process can measurably improve cellular energy production and exercise tolerance.
Research published in Frontiers in Medicine has demonstrated the potential of IHHT in improving physical performance and reducing fatigue in post-COVID patients.
Therapeutic Apheresis
For patients with documented microclots and endothelial dysfunction, therapeutic apheresis (blood filtration) can directly remove inflammatory mediators, fibrin amyloid microclots, and immune complexes from the circulation. This approach, informed by the microclot research of Dr. Beate Jaeger, addresses the vascular component of post-COVID fatigue at its source.
Apheresis modalities used at St. George Hospital include:
- INUSpheresis — a comprehensive filtration approach that removes a broad spectrum of inflammatory and toxic molecules
- H.E.L.P. apheresis — targeting fibrinogen, LDL, and inflammatory proteins
- Immunoadsorption — selectively removing autoantibodies that may drive persistent symptoms
Ozone Therapy
Major autohemotherapy with medical ozone addresses multiple mechanisms of post-COVID fatigue simultaneously:
- Improves oxygen utilization at the cellular level
- Enhances microcirculation and red blood cell flexibility
- Modulates immune function — reducing excessive inflammation while supporting pathogen clearance
- Supports mitochondrial function through improved oxygen metabolism
Graded Exercise and Activity Management
Exercise management in post-COVID fatigue requires careful calibration. Unlike conventional deconditioning, post-COVID fatigue involves post-exertional malaise — where overexertion causes disproportionate symptom worsening lasting days. Our approach includes:
- Heart rate monitoring — staying below the anaerobic threshold to avoid triggering post-exertional malaise
- Pacing strategies — alternating activity and rest, gradually increasing tolerance
- Autonomic reconditioning — specific exercises for POTS and orthostatic intolerance
- Progressive reintroduction — increasing activity only as mitochondrial function and microcirculation improve with treatment
It is essential that exercise prescription follows — not precedes — biological treatment. Pushing patients to exercise before addressing mitochondrial dysfunction and microcirculation often worsens their condition.
Additional Supportive Therapies
- IV glutathione — addressing oxidative stress and supporting detoxification
- High-dose IV vitamin C — anti-inflammatory and immune-modulating
- Coenzyme Q10 — supporting mitochondrial electron transport chain function
- Magnesium and B-vitamin repletion — correcting deficiencies common after COVID-19
- Neurofeedback — for cognitive symptoms and autonomic regulation
The St. George Hospital Post-COVID Inpatient Program
Our two-to-three-week inpatient program for post-COVID fatigue provides an intensive, medically supervised treatment environment that outpatient visits cannot replicate. A typical treatment day includes:
- Morning: Blood tests and clinical assessment, followed by NAD+ or nutrient IV infusion
- Midday: IHHT session (30–40 minutes) or ozone therapy
- Afternoon: Apheresis session (when indicated) or additional IV therapies
- Throughout: Physician monitoring, dietary support, rest periods, and gradual activity
This intensive approach allows us to deliver more therapeutic interventions in two to three weeks than most outpatient programs can provide in six months — and under continuous medical supervision that ensures safety and allows real-time adjustment of the treatment plan.
Frequently Asked Questions About Post-COVID Fatigue Treatment
How long does post-COVID fatigue last without treatment?
Without targeted treatment, post-COVID fatigue can persist for months to years. Studies suggest that 10–20% of COVID-19 patients experience symptoms beyond 12 weeks, and a significant subset remain symptomatic beyond one year. The duration depends on the underlying biological mechanisms — patients with significant mitochondrial damage, microclots, or autoimmune activation tend to have more prolonged courses without intervention.
Can post-COVID fatigue be cured?
Many patients achieve substantial or complete recovery with appropriate treatment — particularly when the underlying mechanisms (mitochondrial dysfunction, microcirculation, immune dysregulation) are specifically addressed. Dr. Julian Douwes emphasizes that early, comprehensive treatment generally produces better outcomes than waiting for spontaneous resolution. However, recovery timelines vary, and some patients require ongoing management.
Is post-COVID fatigue the same as chronic fatigue syndrome (ME/CFS)?
There is significant overlap. Many post-COVID patients meet the diagnostic criteria for ME/CFS, and the underlying mechanisms — mitochondrial dysfunction, immune dysregulation, autonomic dysfunction — are remarkably similar. The treatments that help post-COVID fatigue are often effective for ME/CFS as well, suggesting shared pathophysiology. The key difference is that post-COVID fatigue has a clearly identified trigger, which may facilitate earlier diagnosis and treatment.
What role do microclots play in post-COVID fatigue?
Microclots — specifically fibrin amyloid microclots that resist normal breakdown — are an important research direction in understanding post-COVID syndrome. Dr. Beate Jaeger’s work on endothelial dysfunction and impaired microcirculation suggests that these microclots may restrict oxygen and nutrient delivery to tissues, contributing directly to fatigue, brain fog, and exercise intolerance. Therapeutic apheresis is one approach being used to address this mechanism, though research continues to evolve.
Do I need to come to Germany for treatment?
While many of our post-COVID patients are international — traveling from the US, UK, Middle East, and across Europe — we understand that travel is a significant commitment, especially when you are already experiencing fatigue. Our international patient coordinators can arrange pre-arrival consultations to determine whether our inpatient program is appropriate for your situation and help plan logistics.
Begin Your Recovery
Post-COVID fatigue has a biological basis — and biological treatments are available. If you have been struggling with persistent fatigue after COVID-19, our specialized program at St. George Hospital offers a comprehensive, evidence-informed approach to recovery.
Contact us to discuss your situation:
- Phone: +49 (0)8061 398-0
- Email: info@clinicum-stgeorg.de
- Visit: Contact page